MedTrace Logo

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

NCT07032337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2985

Last updated 2025-06-23

No results posted yet for this study

Summary

Newly diagnosed NMOSD patients

Conditions

  • Neuromyelitis Optica Spectrum Disorder (NMOSD)

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07032337 on ClinicalTrials.gov